PLURMEDIUM SIGNALFINANCIAL10-K

Pluri experienced a substantial decline in accounts receivable and notable reductions in current assets and cash positions, while expanding its subsidiary structure to include new food-related entities.

The dramatic drop in accounts receivable from $19K to $3K, combined with the 29% decline in current assets, suggests either reduced business activity or improved collections efficiency. The company has also restructured to include new subsidiaries focused on food applications (Coffeesai, Kokomodo/Ever After Foods), indicating potential diversification beyond traditional biotech operations.

Comparing 2025-09-17 vs 2024-09-18View on EDGAR →
FINANCIAL ANALYSIS

Pluri's balance sheet reflects a tightening liquidity position with current assets declining meaningfully from $31.1M to $22.1M and cash dropping modestly to $5.9M. The accounts receivable fell substantially, which could indicate either reduced sales activity or accelerated customer payments. Overall, the financial picture suggests a company managing cash carefully while potentially pivoting or expanding into new market segments through its enlarged subsidiary structure.

FINANCIAL STATEMENT CHANGES
Accounts Receivable
Balance Sheet
-84.2%
$19K→$3K

Receivables declined — improved collection efficiency or conservative revenue recognition.

Current Assets
Balance Sheet
-29%
$31.1M→$22.1M

Current assets declined 29% — monitor working capital adequacy and short-term liquidity.

Cash & Equivalents
Balance Sheet
-13.1%
$6.8M→$5.9M

Cash decreased 13.1% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2025-09-17
PRIOR — 2024-09-18
ADDED
Form 10-K Summary 68 i Our financial statements are stated in thousands United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles ( U.S.
In this Annual Report on Form 10-K (this Annual Report ), unless otherwise specified, all dollar, amounts are expressed in United States Dollars.
As used in this Annual Report, unless the context otherwise requires, the terms Pluri , the Company , we , us , and our refer to Pluri Inc., together with its wholly owned Israeli subsidiary, Pluri Biotech Ltd.
and the subsidiaries of Pluri Biotech Ltd., including its wholly owned Israeli subsidiary, Coffeesai Ltd.
( Coffeesai ), its majority-owned Israeli subsidiaries, Kokomodo Ltd.
+7 more — sign up free →
REMOVED
Form 10-K Summary 60 i Our financial statements are stated in thousands United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles, or U.S.
In this annual report, unless otherwise specified, all dollar, amounts are expressed in U.S.
As used in this annual report, the terms we , us , our , the Company , and Pluri mean Pluri Inc., our wholly owned Israeli subsidiary, our majority owned Israeli subsidiary, and the wholly owned subsidiary of our Israeli subsidiary in Germany, unless otherwise indicated or required by the context.
All information in this Annual Report on Form 10-K or Annual Report, relating to shares or price per share reflects the 1-for-8 reverse stock split effected by us on April 1, 2024.
Risk Factors , and expressed from time to time in our filings with the Securities and Exchange Commission, or SEC, could cause actual results and developments to be materially different from those expressed in or implied by such statements.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →